Atlas Trials

Sylimarin, Pyrroloquinoline, Quinone Sodium Salt and Myricetin Assumption Effects

Clinical trial NCT06548503 · COMPLETED

Trial details

NCT number
NCT06548503
Sponsor
University of Padova
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Oxidative StressAlcohol Drinking
Start date
2023-11-01
Primary completion
2023-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.